Our R&D portfolio for hepatitis C
What we have achieved
We delivered a new treatment that is equal to the best hepatitis C drugs, at a fraction of the cost.
What we are doing for people living with hepatitis C
We are now working to help foster an enabling environment for improved availability of hepatitis C diagnostics and treatments in low- and middle-income countries and supporting innovative ‘test-and-treat’ programmes in several countries.
Building capacity, uniting expertise
Initiatives to utilize and strengthen research capacities in low- and middle-income countries and support networks of excellence to sustain public-interest R&D are central to our virtual R&D model.
Partnering for patients
Collaboration is an essential part of how we work. We have forged a diverse range of alliances and research collaborations with over 200 partners in more than 40 countries.
Get our latest news, personal stories, research articles, and job opportunities.